Quest PharmaTech Inc (CVE:QPT) shares were down 3% during trading on Tuesday . The company traded as low as C$0.16 and last traded at C$0.16, approximately 500 shares traded hands during mid-day trading. A decline of 99% from the average daily volume of 39,221 shares. The stock had previously closed at C$0.17.

The stock has a market capitalization of $21.76 million and a price-to-earnings ratio of -5.00. The business has a fifty day moving average of C$0.17 and a 200 day moving average of C$0.13.

About Quest PharmaTech (CVE:QPT)

Quest PharmaTech Inc, a biotechnology company, develops and commercializes antibody based immunotherapeutic products for cancer. It operates in two segments, Biopharmaceutical/Pharmaceutical Products and Consumer/Cosmetic Products. The company focuses on combinatorial immunotherapeutic approaches to cancer by using monoclonal antibodies of the immunoglobulin G or E subclass in combination with chemotherapy/immune-adjuvant.

See Also: Find a Trading Strategy That Works

Receive News & Ratings for Quest PharmaTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quest PharmaTech and related companies with MarketBeat.com's FREE daily email newsletter.